| Clinical data | |
|---|---|
| Trade names | Caprosem |
| Routes of administration |
Intramuscular injection |
| Identifiers | |
|
|
| Synonyms | Testosterone 17β-chloral hemiacetal O-acetate; 17β-(1-(Acetyloxy)-2,2,2-trichloroethoxy)androst-4-en-3-one |
| CAS Number | 13867-82-8 |
| PubChem (CID) | 20056698 |
| ChemSpider | 16739648 |
| UNII | 2X9YIP66ZO |
| Chemical and physical data | |
| Formula | C23H31Cl3O4 |
| Molar mass | 477.847 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
Cloxotestosterone acetate (INN; brand name Caprosem), also known as testosterone 17β-chloral hemiacetal O-acetate, as well as 17β-(1-(acetyloxy)-2,2,2-trichloroethoxy)androst-4-en-3-one, is a synthetic, injected anabolic-androgenic steroid (AAS) and an androgen ether and ester – specifically, the O-acetate ester of cloxotestosterone, the 17β-chloro hemiacetal ether of testosterone. It is administered via intramuscular injection as a 100 mg, 2 mL aqueous suspension and lasts 4 to 6 weeks with a single administration. The drug was first marketed in the early 1960s.